Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration.

    Rechtman E, Danis RP, Pratt LM, Harris A.

    Br J Ophthalmol. 2004 Mar;88(3):344-7.PMID: 14977766 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

    Chaudhary V, Mao A, Hooper PL, Sheidow TG.

    Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

    3.

    Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles

    4.

    Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.

    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.

    Am J Ophthalmol. 2006 Jul;142(1):10-16.PMID: 16815246 [PubMed - indexed for MEDLINE]Related articles

    5.

    Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Am J Ophthalmol. 2006 Apr;141(4):638-45.PMID: 16564797 [PubMed - indexed for MEDLINE]Related articles

    6.

    Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.PMID: 16360209 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response.

    Schadlu R, Kymes SM, Apte RS.

    Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1667-72. Epub 2007 Jun 22.PMID: 17583819 [PubMed - indexed for MEDLINE]Related articles

    8.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.

    Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.

    Retina. 2006 Jul-Aug;26(6):602-12.PMID: 16829800 [PubMed - indexed for MEDLINE]Related articles

    9.

    Combined photodynamic therapy and intravitreal triamcinolone acetonide injection for neovascular age-related macular degeneration with pigment epithelium detachment.

    Axer-Siegel R, Ehrlich R, Avisar I, Kramer M, Rosenblatt I, Priel E, Weinberger D.

    Ophthalmic Surg Lasers Imaging. 2006 Nov-Dec;37(6):455-61.PMID: 17152538 [PubMed - indexed for MEDLINE]Related articles

    10.

    Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone.

    Iwama D, Otani A, Sasahara M, Yodoi Y, Gotoh N, Tamura H, Tsujikawa A, Yoshimura N.

    Br J Ophthalmol. 2008 Oct;92(10):1352-6. Epub 2008 Jul 28.PMID: 18662914 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin.

    Van de Moere A, Sandhu SS, Kak R, Mitchell KW, Talks SJ.

    Ophthalmology. 2005 Nov;112(11):1896-903. Epub 2005 Oct 7.PMID: 16214216 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration]

    Leparmentier A, Arnaud C, Fournie P, Mathis A, Quintyn JC.

    J Fr Ophtalmol. 2007 Feb;30(2):155-60. French. Erratum in: J Fr Ophtalmol. 2007 Mar;30(3):231. Audrey, L [corrected to Leparmentier, A]. PMID: 17318098 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.

    Ruiz-Moreno JM, Montero JA, Zarbin MA.

    Retina. 2007 Apr-May;27(4):458-61.PMID: 17420698 [PubMed - indexed for MEDLINE]Related articles

    14.

    Combination therapy of intravitreal triamcinolone and photodynamic therapy with verteporfin for subfoveal choroidal neovascularization.

    Hussain N, Das T, Rawal H, Kallukuri SB, Mohan Ram LS, Khanna R.

    Indian J Ophthalmol. 2006 Dec;54(4):247-50.PMID: 17090876 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2005 Feb;112(2):301-4.PMID: 15691567 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy.

    Iriyama A, Obata R, Inoue Y, Takahashi H, Tamaki Y, Yanagi Y.

    Graefes Arch Clin Exp Ophthalmol. 2008 Mar;246(3):339-44. Epub 2007 Sep 6.PMID: 17805556 [PubMed - indexed for MEDLINE]Related articles

    17.

    Impact of lesion size on photodynamic therapy with verteporfin of predominantly classic lesions in age related macular degeneration.

    Arias L, Pujol O, Berniell J, Rubio M, Roca G, Castillo L, Acebes E.

    Br J Ophthalmol. 2005 Mar;89(3):312-5.PMID: 15722311 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.

    Gomi F, Ohji M, Sayanagi K, Sawa M, Sakaguchi H, Oshima Y, Ikuno Y, Tano Y.

    Ophthalmology. 2008 Jan;115(1):141-6. Epub 2007 Jun 20.PMID: 17582498 [PubMed - indexed for MEDLINE]Related articles

    19.

    Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

    Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.

    BMC Ophthalmol. 2007 Jun 7;7:10.PMID: 17555600 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.

    Nicolò M, Ghiglione D, Lai S, Nasciuti F, Cicinelli S, Calabria G.

    Retina. 2006 Jan;26(1):58-64.PMID: 16395140 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data